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Abstract
Introduction: The aim of this clinical trial was to compare the degree of short term post-operative irritation after
application of a triamcinolone/demeclocycyline based or a calcium hydroxide based provisional cement.
Methods: A total of 109 patients (55 female and 54 male; mean age: 51 ± 14 years) with primary or secondary
dentinal caries were randomly assigned to the two treatment groups of this biomedical clinical trial (phase III).
Selection criteria were good systemic health and treated teeth, which were vital and showed no symptoms of
pulpitis. Up to three teeth were prepared for indirect metallic restorations, and the provisional restorations were
cemented with a triamcinolone/demeclocycyline (Ledermix) or a calcium hydroxide (Provicol) based material. The
intensity of post-operative pain experienced was documented according to the VAS (4, 12, 20, 24, and 82 h) and
compared to VAS baseline.
Results: A total of 159 teeth were treated (Ledermix: 83 teeth, Provicol: 76 teeth). The minor irritation of the teeth,
experienced prior to treatment, was similar in both groups; however, 4 h after treatment this value was
significantly higher in the Provicol group than in the Ledermix group (p < 0.005, t-test). After 12 h, the difference
was no longer significant. The number of patients taking analgesics for post-treatment pain was higher in the
Provicol group (n = 11/53) than in the Ledermix group (n = 3/56).
Conclusions: The patients had no long term post-operative pain experience in both groups. However, within the
first hours after cementation the sensation of pain was considerably higher in the Provicol group than in the
Ledermix group.
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Introduction
During cavity preparation pulpal inflammatory reactions
should be avoided. Unpleasant sensory experiences and
acute pain, which in many cases can go along with pul-
pal irritation up to an inflammation, may have various
causes such as bacterial infections or chemical, physical
or traumatic events. Cavity preparations, especially
extensive prosthodontic preparations with a considerable
removal of dentine, can be considered as particularly
traumatic. Various authors have investigated the possible
impact of prosthodontic preparations like full or partial
crowns, involving an extensive loss of dentine, on the
pulp tissues [1-3]. They reported that after an observa-
tion period of five years approximately 5% of the pre-
pared teeth showed periapical radiological changes.
Moreover, according to Bergenholtz et al. [4], necrosis
occurs more frequently (15%-32%) in abutment teeth,
especially when considering observation periods of more
than 5 years. Cheung et al. [5] report similar results,
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occurs more frequently in maxillary anterior teeth.
Hodosh et al. [6] examined temporary interim
cements for the cementation of provisional crowns
regarding the aspect of a possible reduction of incidence
and severity of pain after tooth preparation. It was
shown in this study that a temporary cement, containing
4% potassium nitrate (KNO3) in a zinc oxide-eugenol
(ZOE) base cement, was significantly more effective in
reducing pain after tooth preparation than a cement
containing only ZOE.
Glucocorticoids are drugs, frequently employed to
avoid or reduce inflammation occurring after injuries or
traumatic dental procedures. In addition, they can inhi-
bit the progression of an inflammation, which would
ultimately lead to necrosis of the pulp tissue. The anti-
inflammatory effect of glucocorticoids, employed in the
treatment of vital pulps after direct pulp capping, was
first described by Rapoport et al. [7]. Later, glucocorti-
coids alone or in mixtures with antibiotics were applied
as direct pulp capping agents or as liners in deep cav-
ities to reduce pulpal pain [8-11]. Ledermix paste, devel-
oped by Schroeder [12], is a mixture of a glucocorticoid
(triamcinolone) and an antibiotic (demeclocycline).
Nowadays, two different types of Ledermix preparations
are commercially available, which differ mainly in their
consistency, and only slightly in their chemical composi-
tion. These preparations are Ledermix paste (1% triam-
cinolone, 3% demeclocycline-calcium) and Ledermix
cement (0.7% triamcinolone, 3% demeclocycline-
calcium).
According to various authors [13,14] the anti-bacterial
and anti-inflammatory effects of Ledermix justify its
employment, when inflammatory pulp conditions and
apical lesions have been diagnosed. Schroeder [12]
described the local application of glucocorticoids as a
very effective therapy for pain reduction, especially in
inflammatory pulp processes. Several authors [15-19]
have discussed the potential anti-bacterial and anti-
inflammatory effects of steroids, antibiotics, a combina-
tion of both agents, and calcium hydroxide in different
investigations, often with controversial results. Hume et
a l .[ 1 5 ] ,u s i n gr a d i o - l a b e l e d
3H-triamcinolone, observed
that the constituents of Ledermix were released into
dentinal areas close to the pulp. The authors claim that
immunosuppression, a possible side effect of long term
corticoid application, can favor the progression of pulp
disease. In his review, Mohammadi [19] reported that
the application of glucocorticoid steroids has been
found to be effective in reducing pain following endo-
dontic treatment. Sazak et al. [16] examined the teeth of
dogs histopathologically for signs of pulp inflammation
and formation of tertiary dentine after pulp exposure
and application of calcium hydroxide/Ledermix or
calcium hydroxide alone. After an observational period
of 90 days, no difference was found between the two
groups regarding the formation of reparative dentine.
Ehrmann et al. [17] showed that the employment of
Ledermix resulted in a reduction of endodontic post-
treatment pain.
For the temporary cementation of provisional crowns,
ZOE based cements, and those containing calcium
hydroxide or eugenol, are most frequently used. A few
studies can be found, dealing with the consistencies and
retentive properties of various provisional cements
[20-22] however, the aspect of pain reduction after
tooth preparation was not examined. In these studies,
either the retention of provisional crowns luted with dif-
ferent temporary cements [21] or the effect of the tem-
porary cements on the bond strength of the final
cementation with resin based luting cements to dentine
[20,22] were examined.
The aim of this clinical trial was to observe and com-
pare the degree of short term post-traumatic pain, caused
by irritation during cavity preparation, after application
of a triamcinolone/demeclocycline or a calcium hydro-
xide based temporary cement. Only vital teeth with pri-
mary or secondary carious lesions with an extensive loss
of dentine, in need of indirect restorations and without
any sign of pulpal inflammation were included. The pro-
visional restorations were luted with Ledermix cement or
Provicol. By means of specific pain diaries the patients
recorded the intensity of post-operative pain experienced
at different time points after the dental treatment, and in
addition provided information about amount and fre-
quency of intake of analgesic drugs.
Materials and methods
Ethical approval and patient consent
This clinical trial was approved by the Institutional
Review Board of the University of Mainz, the Ethics
Committee (Nr: 837.033.07 5568) and the Federal Insti-
tute for Drugs and Medical Devices (BfArM; Nr:
4032703). The study was conducted according to the
principles of the Declaration of Helsinki in the revised
form of Tokyo und Venice. Furthermore, the rules of
the German Drug Law (AMG) were followed. All
patients who met the selection criteria and were
included in this examination were informed verbally and
in written form about the risks and benefits of the study
and consented to participate. The text of the written
informed consent of the patients to participate in the
clinical trial was attached to the study protocol. It was
signed by the patients prior to enrolment in the study.
One copy was given to the patient; the other stayed
with the clinical investigator because of the need for
confidentiality, and to have it as certificate for the
patient’s informed consent on hand at all times.
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The study was conducted according to a 1-period, 2-
parallel-groups, block-randomized design, and compari-
sons were made between the two patient groups.
The trial was carried out as an observer-blind, refer-
ence-controlled, mono-centric phase III study in
patients after dental treatment of teeth with dentinal
caries and/or defective filling margins, leading to a nor-
mal or considerable loss of hard tissue (dentine).
Inclusion criteria for this clinical trial were adult
patients aged up to 75 years and good systemic health.
The cardiovascular paramete r sa sw e l la st h ep a t i e n t s ’
height and weight for the determination of the BMI
index were determined and recorded to avoid possible
general health complications. Exclusion criteria were
pregnancy, constant medication within the last six
months, mental illness, physical disabilities, neuropathies
or severe cardiovascular disease, hypersensitivities to
corticoids or tetracycline. All patients had one to three
dentine carious lesions of primary or secondary origin,
and an indirect metallic restoration (inlay/onlay, partial
or full crowns) with a considerable loss of dentine was
indicated. Prior to tooth preparation, all teeth had to be
vital and show a negative reaction to percussion. Teeth
were excluded, when the presence of a reversible or irre-
versible pulp inflammation was suspected.
Patients reporting a pre-treatment pain score of 50 or
more on a VAS (Visual Analogue Scale) were excluded
from the study. To fulfill the quality criteria of decision,
n = 45 patients per group were required [23]. Assuming
a drop-out rate of about 10%, 50 patients per group had
to be included into the study.
Coding and randomization of the patient collective
The randomization code was produced by SAM GmbH
(Greifswald, Germany). Each patient was randomly
assigned to the investigational or the reference drug,
using a computer-generated random permutation proce-
dure (SAS
® Proc PLAN). Randomization was performed
in blocks. The size of the blocks was defined only in the
randomization list. This list was not available to the
investigator for the second visit (observer blind). One
copy of the master randomization code was kept at
SAM GmbH.
Clinical procedures
For this clinical trial originally 235 patients of both gen-
ders were considered; however, only 110 patients met
the inclusion criteria, and one patient dropped out due
to an illness. The randomization of the patients was car-
ried out after patient recruitment and enrolment in the
study.
A total of 109 patients were enrolled in the study (55
female and 54 male). The patients were between 22 and
74 years of age (mean value: 51 ± 14 years). After ran-
domization, the two patient groups were matched for
age range, gender and type of restoration, as is shown in
Table 1. Based on the process of randomization, in 56
patients (31 female, 25 male; aged 23-74 years) 83 teeth
were treated with Ledermix cement, and in 53 patients
(29 male and 24 female; aged 22-72 years) 76 teeth were
treated with Provicol. Prior to the tooth preparation, the
patients had to assess the pain perception of each
respective tooth with the help of a visual analogous pain
scale (VAS: 0-100). Five calibrated dentists with at least
five years of experience carried out the different tooth
preparations for crowns and other indirect restorations
involving loss of dentine structure. The distribution of
the types of final restoration after randomization is very
similar in both groups (Table 1). A maximum of three
teeth per patient were included in the study, the mean
number of teeth treated per patient was 1.48 for the
Ledermix group, and 1.44 for the Provicol group. In
most cases, an extensive loss of dentine was observed
and a self-adhesive core building material was used
(Luxacore DMG, Hamburg, Germany). After the tooth
preparations and cementation of the provisional restora-
tion, the patients received a pain diary, which was
explained in detail to all participants at the beginning of
this clinical trial, and they had to complete it up to
three days following the dental treatment. In addition to
keeping the pain diary, all patients were questioned via
telephone (on the first and third day after treatment)
about their actual well-being and possible pain sensa-
tions. The patients were appointed for the definitive
cementation of the indirect restoration 12 ± 3 days after
the initial treatment (second office visit). At that
appointment they were requested to bring along the
pain diary. The results of the sensitivity and percussion
tests and the documentation of eventual pain and intake
of analgesics (Ibuprofen 400 mg, three times a day or
Table 1 Patients’ data and type of restorations in the
Ledermix and the Provicol groups
Number of patients
n = 109
Ledermix group
n=5 6
Provicol group
n=5 3
Age (years) (mean ± SD;
range)
53.3 ± 13.7; 23 -74 49.2 ± 14.6; 22-72
Males 25 (44.6%) 29 (54.7%)
Females 31 (55.4%) 24 (45.3%)
Number of teeth
(n = 159)
83 (1.48 per
patient)
76 (1.44 per
patient)
Type of tooth preparation 42 (50.6%) 35 (46.1%)
Crowns 27 (32.5%) 21 (27.6%)
Partial crowns 14 (16.9%) 20 (26.3%)
inlay/onlay core restoration 54 (65.1%) 45 (59%)
Baseline pain (VAS: 0-100)
(mean ± SD)
5.6 ± 8.8 4.3 ± 6.8
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eCRF software (electronic Case Report Form/Greifswald,
Germany). Subsequently, the temporary restorations
were removed and the entire cavity was thoroughly dis-
infected with 0.1% chlorhexidine (Chlorhexamed Fluid,
GlaxoSmithKline/München, Germany). Then the perma-
nent restoration was luted with a self-adhesive universal
luting cement (RelyX Unicem, 3 M ESPE, Seefeld, Ger-
many). Twenty-eight ± 3 days after the first treatment,
the patients were appointed for a control visit (third
office visit). The tooth sensitivity, sensitivity to percus-
sion, occlusion, as well as the patients’ general condi-
tions were recorded.
Test materials
After the completion of the cavity preparation for an
indirect restoration, the teeth received a temporary
restoration made from a resin-based material (Protemp
4, 3 M ESPE, Seefeld, Germany). This temporary
restoration was cemented with Ledermix (Riemser Arz-
neimittel AG/Greifswald, Germany) or with Provicol/C/
QM (Voco GmbH/Cuxhaven, Germany). Ledermix
cement contains demeclocycline and triamcinolone acet-
onide, while Provicol is a calcium hydroxide-based,
eugenol-free temporary cement. The temporary restora-
tions remained in place for up to 12 days (± 3), after
which they were removed, and the teeth received their
final restorations.
Statistical analysis
The primary outcome variable is the difference (Δ)
between the VAS scores after treatment compared to
pre-treatment VAS scores. The arithmetic means, stan-
dard deviations and the corresponding two-sided 90%
confidence intervals of these Δ-values were calculated.
The assessment was done using the SAS
® package. The
one sided-t-test was used for statistical evaluation (a =
0.05). All other variables were evaluated in the sense of
an explorative analysis. All statistical tests that were car-
ried out at secondary variables are strictly interpreted in
an exploratory sense to generate hypotheses, not to
decide on hypotheses.
Results
A total of 109 patients were enrolled in the study (55
female and 54 male). The patients were between 22 and
74 years of age (mean value: 51 ± 14 years). Based on
the process of randomization, in 56 patients (31 female,
25 male; aged 23-74 years) 83 teeth were treated with
Ledermix cement, and in 53 patients (29 male and 24
female; aged 22-72 years) 76 teeth were treated with
Provicol.
There were no significant differences between the two
groups with regard to age, gender and blood pressure
values. Based on the performed randomization, one to
three teeth were treated per patient. The tooth related
evaluation of pain perception showed in the Provicol
group at the beginning of the observation time (up to
12 hours) higher pain perception scores than in the
Ledermix group. The greatest differences regarding the
pain perception were observed 4 h after tooth prepara-
tion, when the patients in the Ledermix group showed
statistically significant lower pain perception scores than
those in the Provicol group (p < 0.005). After twelve
hours, the pain perception scores in the Ledermix group
were still lower; however, the difference was no longer
statistically significant (Figure 1).
For the remaining observational period of three days,
almost no differences were reported. The analysis of the
pain diaries showed that patients in the Provicol group
had a higher demand for analgesics. Only 3/56 patients
from the Ledermix group took analgesics (each 1× Ibu-
profen 400 mg). In contrast, 11/53 patients from the
Provicol group took analgesics, four of them took more
than 1 × Ibuprofen 400 mg during the first day, and
four patients took analgesics for more than one day.
During the entire observational period of 28 days, no
severe pain was observed, all teeth remained sensitive
and none showed a positive response to percussion indi-
cating an irreversible pulpitis, and no tooth discolora-
tion, based on the short term placement of Ledermix
cement, was recorded. None of the teeth showed perira-
dicular changes on the x-rays, and no endodontic treat-
ment was performed. In addition, no long term post-
operative pain experience was observed in both groups.
Figure 1 VAS (score: 0-100) pain scale taken from the patients’
diaries during the course of the first study days (mean ± CI,
confidence interval).
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After tooth preparations, which involve a considerable
loss of dentine, a rapid and efficient pain relief is of
major importance. In the present prospective, rando-
mized, observer-blind, reference-controlled phase III
clinical study, the influence of Ledermix cement in
reducing post-operative pain was compared to calcium
hydroxide-based Provicol cement. Since its introduction
by Schroeder [12], the application of Ledermix has been
recommended mainly for endodontic treatment, and for
the relief of pain induced by pulp irritation. The efficacy
of its active agents has been controversially discussed.
Different authors report the advantages of using Leder-
mix for pain reduction in endodontic procedures
[10,17,19,24]. However, other authors were not able to
report significant differences between Ledermix and cal-
cium hydroxide after intraradicular application with
regard to pain reduction [25,26]. To the best of our
knowledge, there are only few studies reporting the effi-
cacy of Ledermix as temporary cement on vital teeth,
especially in cases of extensive crown and cavity pre-
parations. Abbott et al. [27] report a beneficial effect of
Ledermix in the treatment of cracked teeth with clinical
signs of reversible pulpitis. In the present investigation,
a possible reduction of post-traumatic pain by two tem-
porary cements (Ledermix and Provicol) was investi-
gated. An equally important aspect was the possible
reduction of microorganisms, remaining behind after
the removal of carious lesions. As pain is a subjective
sensation and can easily be influenced, all patients were
asked to keep a pain diary for a defined period of time
after the treatment. Pierce et al. [28] were able to show
histologically that the application of Ledermix resulted
in a reduction of inflammatory external root resorption
and thus exerted an inhibitory influence on rapidly pro-
gressing root resorptions in injured teeth. Glucocorti-
coids suppress cell-mediated immunity by directly
inhibiting all steps within the eicosanoids synthesis. As a
consequence, the steroidal component of the Ledermix
is able to suppress the cell-mediated immunity [28].
Some authors raise concern that steroids might have an
inhibiting effect on the hypophysical system. However, it
could be shown that the maximal dose of glucocorti-
coids applied within the root canal has only a local
effect and is therefore not high enough to exert a sys-
temic effect [29].
The present study revealed that teeth, which received
Ledermix cement, showed a significantly lower pain per-
ception 4 h after tooth preparation, when compared to
Provicol cement; however, after 24 h no significant dif-
ference between the two groups could be observed.
Over an observational period of four weeks, no cases of
tooth sensitivity loss were reported, and in addition, the
patients had no long term post-operative pain experi-
ence in both groups. Both tested materials can be
recommended as temporary cements.
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